[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

IRON Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.71%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $78,556,640.40

Disc Medicine Insider Trading History Chart

Disc Medicine Share Price & Price History

^$54.20

▲ +0.83 (1.56%)

As of 11/28/2023 01:00 AM ET

Days: 30 | 90 | 365

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

Disc Medicine Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/22/2023	Rahul Khara	General Counsel	Sell	10,000	$51.73	$517,300.00
11/14/2023	Rahul Khara	General Counsel	Sell	4,900	$50.61	$247,989.00
11/3/2023	Rahul Khara	General Counsel	Sell	100	$50.00	$5,000.00
9/16/2023	Venture Fund X L.P. Atlas	Major Shareholder	Sell	2,115	$53.22	$112,560.30	1,593,785
9/14/2023	Venture Fund X L.P. Atlas	Major Shareholder	Sell	94,440	$53.05	$5,010,042.00	1,856,794
9/1/2023	Joanne Bryce	CFO	Sell	1,000	$52.99	$52,990.00	1,260
8/15/2023	Kevin Bitterman	Director	Sell	72,931	$52.40	$3,821,584.40	882,224
8/15/2023	William Jacob Savage	insider	Sell	7,672	$52.95	$406,232.40
8/14/2023	Venture Fund X L.P. Atlas	Major Shareholder	Sell	175,000	$52.59	$9,203,250.00	2,062,303
8/9/2023	William Jacob Savage	Insider	Sell	8,269	$49.83	$412,044.27	7,672
8/1/2023	Joanne Bryce	CFO	Sell	4,521	$49.91	$225,643.11	1,260
6/30/2023	Brian Richard Macdonald	Insider	Sell	4,324	$45.05	$194,796.20	12,876
6/28/2023	Holdings A/S Novo	Major Shareholder	Sell	1,250,000	$46.10	$57,625,000.00	1,090,772
6/28/2023	Joanne Bryce	CFO	Sell	10,072	$49.95	$503,096.40	1,260
6/28/2023	William Jacob Savage	Insider	Sell	4,384	$49.98	$219,112.32	15,941

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for Disc Medicine (NASDAQ:IRON)

Institutional Buying and Selling by Quarter

Disc Medicine Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/24/2023	Deutsche Bank AG	4,609	$0.22M	0.0%	+27.3%	0.019%
11/22/2023	Polar Capital Holdings Plc	546,915	$25.69M	0.2%	+28.2%	2.266%
11/15/2023	The Manufacturers Life Insurance Company	12,525	$0.59M	0.0%	+84.3%	0.055%
11/15/2023	Legal & General Group Plc	8,775	$0.41M	0.0%	+848.6%	0.038%
11/15/2023	Acuta Capital Partners LLC	138,198	$6.49M	4.4%	-0.9%	0.604%
11/15/2023	Adage Capital Partners GP L.L.C.	1,308,405	$61.47M	0.1%	+12.5%	5.719%
11/15/2023	Alps Advisors Inc.	16,900	$0.79M	0.0%	+16.1%	0.074%
11/14/2023	Schonfeld Strategic Advisors LLC	12,700	$0.60M	0.0%	+76.4%	0.056%
11/14/2023	California State Teachers Retirement System	8,960	$0.42M	0.0%	+248.2%	0.039%
11/14/2023	Trexquant Investment LP	12,534	$0.59M	0.0%	N/A	0.055%
11/14/2023	Profund Advisors LLC	10,552	$0.50M	0.0%	N/A	0.046%
11/13/2023	Atlas Venture Life Science Advisors LLC	2,745,335	$128.98M	20.0%	-20.7%	11.999%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	16,642	$0.78M	0.0%	N/A	0.073%
11/13/2023	CHI Advisors LLC	25,000	$1.17M	0.4%	-80.0%	0.109%
11/13/2023	Northern Trust Corp	89,038	$4.18M	0.0%	+27.2%	0.389%
11/13/2023	EAM Investors LLC	51,111	$2.40M	0.5%	+8.3%	0.223%
11/13/2023	Invesco Ltd.	161,213	$7.57M	0.0%	+45.7%	0.705%
11/13/2023	FMR LLC	305,433	$14.35M	0.0%	-5.5%	1.335%
11/13/2023	Rafferty Asset Management LLC	63,132	$2.97M	0.0%	N/A	0.276%
11/9/2023	Rhumbline Advisers	13,936	$0.66M	0.0%	+36.5%	0.061%
11/9/2023	Deutsche Bank AG	4,609	$0.22M	0.0%	+27.3%	0.020%
11/9/2023	Citigroup Inc.	26,547	$1.25M	0.0%	+1,053.2%	0.116%
11/9/2023	UBS Group AG	19,016	$0.89M	0.0%	+62.6%	0.083%
11/8/2023	Charles Schwab Investment Management Inc.	84,200	$3.96M	0.0%	+309.6%	0.368%
11/8/2023	Swiss National Bank	17,400	$0.82M	0.0%	N/A	0.076%
11/7/2023	Virtus ETF Advisers LLC	2,014	$95K	0.1%	-9.2%	0.009%
11/7/2023	Barclays PLC	31,561	$1.48M	0.0%	+1,932.3%	0.138%
11/6/2023	Assenagon Asset Management S.A.	74,164	$3.48M	0.0%	-70.0%	0.324%
11/6/2023	Victory Capital Management Inc.	137,523	$6.46M	0.0%	N/A	0.601%
10/27/2023	TD Asset Management Inc	20,214	$0.95M	0.0%	+260.5%	0.088%
10/26/2023	Strs Ohio	600	$28K	0.0%	N/A	0.003%
10/24/2023	Bank of New York Mellon Corp	30,550	$1.44M	0.0%	+22.3%	0.134%
9/21/2023	Barclays PLC	1,553	$69K	0.0%	-72.4%	0.007%
8/24/2023	Perceptive Advisors LLC	742,838	$32.98M	1.0%	N/A	3.752%
8/22/2023	CHI Advisors LLC	125,139	$5.56M	1.7%	N/A	0.632%
8/21/2023	California State Teachers Retirement System	2,573	$0.11M	0.0%	N/A	0.013%
8/16/2023	Nuveen Asset Management LLC	35,005	$1.55M	0.0%	N/A	0.177%
8/15/2023	Alliancebernstein L.P.	7,280	$0.32M	0.0%	N/A	0.037%
8/15/2023	Wells Fargo & Company MN	3,199	$0.14M	0.0%	+12,203.8%	0.016%
8/15/2023	Walleye Capital LLC	35,804	$1.59M	0.0%	N/A	0.181%
8/15/2023	Woodline Partners LP	68,146	$3.03M	0.0%	N/A	0.344%
8/15/2023	Point72 Asset Management L.P.	125,200	$5.56M	0.0%	N/A	0.632%
8/15/2023	Sphera Funds Management LTD.	170,578	$7.57M	1.2%	-22.5%	0.862%
8/15/2023	Stifel Financial Corp	8,760	$0.39M	0.0%	-36.2%	0.044%
8/15/2023	Hilltop Holdings Inc.	7,100	$0.32M	0.0%	N/A	0.036%
8/15/2023	Boothbay Fund Management LLC	48,941	$2.17M	0.0%	N/A	0.247%
8/15/2023	Bain Capital Life Sciences Investors LLC	1,332,548	$59.17M	6.1%	-33.1%	6.730%
8/15/2023	Citadel Advisors LLC	651,320	$28.92M	0.0%	+280.4%	3.289%
8/14/2023	Ergoteles LLC	5,402	$0.24M	0.0%	N/A	0.027%
8/14/2023	Cormorant Asset Management LP	225,000	$9.99M	0.6%	N/A	1.136%
8/14/2023	Tudor Investment Corp Et Al	12,335	$0.55M	0.0%	N/A	0.062%
8/14/2023	Schonfeld Strategic Advisors LLC	7,200	$0.32M	0.0%	N/A	0.036%
8/14/2023	State Street Corp	139,403	$6.19M	0.0%	+862.3%	0.704%
8/14/2023	Rock Springs Capital Management LP	363,468	$16.14M	0.4%	+16.0%	1.836%
8/14/2023	Nuveen Asset Management LLC	35,005	$1.55M	0.0%	N/A	0.177%
8/14/2023	Polar Capital Holdings Plc	426,612	$18.94M	0.1%	N/A	2.155%
8/14/2023	Ghisallo Capital Management LLC	20,000	$0.89M	0.1%	N/A	0.101%
8/11/2023	Renaissance Technologies LLC	68,890	$3.06M	0.0%	+351.1%	0.348%
8/11/2023	BlackRock Inc.	502,549	$22.31M	0.0%	+2,041.5%	2.538%
8/11/2023	Ameritas Investment Partners Inc.	639	$28K	0.0%	N/A	0.003%
8/11/2023	Harvard Management Co. Inc.	8,452	$0.38M	0.0%	-66.2%	0.043%
8/11/2023	The Manufacturers Life Insurance Company	6,796	$0.30M	0.0%	N/A	0.034%
8/11/2023	Franklin Resources Inc.	157,255	$6.98M	0.0%	N/A	0.794%
8/11/2023	Geode Capital Management LLC	147,055	$6.53M	0.0%	+212.6%	0.743%
8/11/2023	JPMorgan Chase & Co.	5,997	$0.27M	0.0%	N/A	0.030%
8/11/2023	PNC Financial Services Group Inc.	4,010	$0.18M	0.0%	N/A	0.020%
8/11/2023	Northern Trust Corp	69,975	$3.11M	0.0%	N/A	0.353%
8/11/2023	ExodusPoint Capital Management LP	52,800	$2.34M	0.0%	-25.6%	0.267%
8/10/2023	MetLife Investment Management LLC	4,194	$0.19M	0.0%	N/A	0.021%
8/10/2023	Monashee Investment Management LLC	45,000	$2M	0.5%	N/A	0.227%
8/10/2023	Charles Schwab Investment Management Inc.	20,556	$0.91M	0.0%	N/A	0.104%
8/10/2023	Citigroup Inc.	2,302	$0.10M	0.0%	-90.8%	0.012%
8/9/2023	TD Asset Management Inc	5,607	$0.25M	0.0%	N/A	0.028%
8/8/2023	Rhumbline Advisers	10,210	$0.45M	0.0%	N/A	0.052%
8/4/2023	American International Group Inc.	3,723	$0.17M	0.0%	N/A	0.019%
8/3/2023	Barclays PLC	1,553	$69K	0.0%	-72.4%	0.008%
8/3/2023	Bank of New York Mellon Corp	24,983	$1.11M	0.0%	N/A	0.126%
7/25/2023	Assenagon Asset Management S.A.	247,400	$10.99M	0.0%	+300.3%	1.249%
7/13/2023	Thompson Davis & CO. Inc.	6,800	$0.30M	0.3%	N/A	0.034%
5/16/2023	Susquehanna International Group LLP	37,213	$0.79M	0.0%	+101.2%	0.196%
5/16/2023	Jane Street Group LLC	19,252	$0.41M	0.0%	N/A	0.101%
5/16/2023	Sphera Funds Management LTD.	220,013	$4.66M	0.8%	N/A	1.158%
5/16/2023	State Street Corp	14,487	$0.31M	0.0%	+42.2%	0.076%
5/16/2023	Geode Capital Management LLC	47,038	$1M	0.0%	+73.2%	0.248%
5/16/2023	Bain Capital Life Sciences Investors LLC	1,990,914	$42.19M	5.3%	N/A	10.480%
5/15/2023	Logos Global Management LP	525,000	$11.13M	1.6%	N/A	2.763%
5/15/2023	Two Sigma Investments LP	24,150	$0.51M	0.0%	N/A	0.127%
5/15/2023	Ghost Tree Capital LLC	100,000	$2.12M	0.6%	N/A	0.526%
5/12/2023	Renaissance Technologies LLC	15,270	$0.32M	0.0%	+17.7%	0.080%
5/12/2023	BlackRock Inc.	23,467	$0.50M	0.0%	+16.9%	0.124%
5/12/2023	Bank of America Corp DE	2,682	$57K	0.0%	+134,000.0%	0.014%
5/12/2023	UBS Group AG	5,243	$0.11M	0.0%	-26.3%	0.028%
5/11/2023	FMR LLC	151,699	$3.22M	0.0%	-21.5%	0.798%
5/11/2023	ExodusPoint Capital Management LP	70,966	$1.50M	0.0%	+134.7%	0.374%
5/11/2023	Citigroup Inc.	25,080	$0.53M	0.0%	+393.0%	0.132%
5/4/2023	Barclays PLC	5,619	$0.12M	0.0%	+2,709.5%	0.030%
4/18/2023	Assenagon Asset Management S.A.	61,805	$1.31M	0.0%	-9.7%	0.325%
4/14/2023	BML Capital Management LLC	208,161	$4.41M	3.8%	-58.4%	1.096%
2/15/2023	Trustees of Columbia University in the City of New York	110,488	$2.20M	4.5%	N/A	2.552%
2/15/2023	Millennium Management LLC	14,761	$0.29M	0.0%	N/A	0.341%

Data available starting January 2016

Disc Medicine, Inc., together with its subsidiaries, operates as a clinical-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and MWTX-003 for the treatment of polycythemia vera, and other hematologic disorders. The company's preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. The company was founded in 2017 and is headquartered in Watertown, Massachusetts.

Today's Range

Now: $54.20

$52.26

$54.28

50 Day Range

MA: $47.81

$42.17

$54.20

52 Week Range

Now: $54.20

$11.80

$57.70

Volume

176,194 shs

Average Volume

147,073 shs

Market Capitalization

$1.31 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Disc Medicine?: Disc Medicine's top insider shareholders include:
Venture Fund X LP Atlas (Major Shareholder)
Holdings A/S Novo (Major Shareholder)
Kevin Bitterman (Director)
William Jacob Savage (Insider)
Brian Richard Macdonald (Insider)
Joanne Bryce (CFO)
Rahul Khara (General Counsel)
Learn More about top insider investors at Disc Medicine.
Who are the major institutional investors of Disc Medicine?: Disc Medicine's top institutional investors include:
Atlas Venture Life Science Advisors LLC — 12.00%
Adage Capital Partners GP L.L.C. — 5.72%
Polar Capital Holdings Plc — 2.27%
FMR LLC — 1.33%
Invesco Ltd. — 0.70%
Acuta Capital Partners LLC — 0.60%
Learn More about top institutional investors of Disc Medicine stock.
Which institutional investors are selling Disc Medicine stock?: In the previous quarter, IRON stock was sold by these institutional investors:
Atlas Venture Life Science Advisors LLC
Assenagon Asset Management S.A.
CHI Advisors LLC
FMR LLC
Acuta Capital Partners LLC
Virtus ETF Advisers LLC
Within the last year, company insiders that have sold Disc Medicine company stock include:
Venture Fund X LP Atlas (Major Shareholder)
Holdings A/S Novo (Major Shareholder)
Kevin Bitterman (Director)
William Jacob Savage (Insider)
Brian Richard Macdonald (Insider)
Joanne Bryce (CFO)
Rahul Khara (General Counsel)
Learn More investors selling Disc Medicine stock.
Which institutional investors are buying Disc Medicine stock?: During the previous quarter, IRON stock was purchased by institutional investors including:
Adage Capital Partners GP L.L.C.
Victory Capital Management Inc.
Polar Capital Holdings Plc
Charles Schwab Investment Management Inc.
Rafferty Asset Management LLC
Invesco Ltd.
Barclays PLC
Citigroup Inc.

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

IRON Insider Trading

Disc Medicine Insider Trading History Chart

Disc Medicine Share Price & Price History

Disc Medicine Insider Trading History

SEC Filings (Institutional Ownership Changes) for Disc Medicine (NASDAQ:IRON)

Institutional Buying and Selling by Quarter

Disc Medicine Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Disc Medicine?

Who are the major institutional investors of Disc Medicine?

Which institutional investors are selling Disc Medicine stock?

Which institutional investors are buying Disc Medicine stock?